Covington advised Humacyte on the deal. Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland...
You must be a Standard 1 Year member to access this content.
Covington advised Marathon Asset Management LP on the deal. Marathon Asset Management LP announced a non-dilutive term loan for up to $100 million to Theratechnologies Inc. Marathon...
You must be a Standard 1 Year member to access this content.
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
You must be a Standard 1 Year member to access this content.
